期刊文献+

早期乳腺癌根治术后辅助放疗指征探讨

Indications for postmastectomy radiotherapy in early breast cancer patients
原文传递
导出
摘要 目的 探讨腋窝淋巴结阳性数为1~3个的早期乳腺癌患者根治术后辅助放疗的指征.方法 回顾性分析根治术后并经病理证实腋窝淋巴结阳性数为1~3个的早期乳腺癌患者92例,腋窝淋巴结阳性数为1、2、3个的患者数分别为40、30、22例.其中45例接受同侧胸壁、内乳区及锁骨上淋巴引流区放疗.定义预后指数≥4分者为高危患者,<4分者为低危患者.采用Kaplan-Meier法计算生存率,并用Logrank法进行检验.结果 放疗患者和未放疗患者的5年生存率分别为93.5%和86.4%(x2=3.43,P>0.05),10年生存率分别为73.0%和56.8%(x2=2.82,P>0.05),局部复发率为6.7%和19.1%(x2=4.66,P<0.05).低危和高危患者中未放疗患者的10年生存率分别为73.0%和56.8%(x2=3.45,P>0.05),局部复发率分别为11.0%和24.0% (x2=4.64,P<0.05).低危和高危患者中接受放疗患者的10年生存率分别为82.0%和72.3%(x2=4.07,P<0.05),局部复发率分别为11.0%和5.0%(x2=5.64,P<0.05).结论 对腋窝淋巴结阳性数为1~3个的早期乳腺癌根治术后且预后指数为高危的患者,建议术后行胸壁和同侧锁骨上淋巴结辅助放疗. Objective To explore the indications for postmastectomy radiotherapy in early breast cancer patients with 1-3 positive axillary lymph nodes.Methods Ninety-two early breast cancer patients with 1-3 pathologically confirmed positive axillary lymph nodes after radical mastectomy were retrospectively analyzed.Of these patients,45 received irradiation to the lateral chest wall,internal mammary chain and supraclavicular area.The prognostic index ≥ 4 was considered as high-risk,while <4 as the low-risk.Survival analysis was performed using the Kaplan-Meier method.The Logrank test was used for the comparison of survival curves between different groups.Results The 5-year survival rates of patients with and without radiotherapy were 93.5% and 86.4% (x2=3.43,P>0.05),the 10-year survival rates were 73.0% and 56.8%(x2=2.82,P>0.05),the 10-year local recurrence rates wcrc 6.7% and 19.1% (x2=4.66,P<0.05).The 10-year survival rates of patients with low risk and high risk without radiotherapy were 73.0% and 56.8% (x2=3.45,P>0.05),while the local recurrence rates were 11.0% and 24.0% (x2=4.64,P<0.05).The 10-year survival rates of patients with low risk and high risk with radiotherapy were 82.0% and 72.3% (x2=4.07,P<0.05),while the local recurrence rates were 11.0% and 5.0% (x2=5.64,P<0.05).Conclusion The early breast cancer patients with 1-3 positive axillary lymph nodes after radical mastectomy and the prognostic index suggests "high-risk" should receive irradiation to the chest wall and supraclavicular area.
出处 《国际放射医学核医学杂志》 2013年第5期287-291,共5页 International Journal of Radiation Medicine and Nuclear Medicine
关键词 乳腺肿瘤 淋巴结 肿瘤复发 局部 乳房切除术 根治性 放射疗法 Breast neoplasms Lymph nodes Neoplasm recurrence, local Mastectomy, radical Radiotherapy
  • 相关文献

参考文献21

  • 1Recht A, Edge SB, Solin LJ, et al. Postmastectomy radiotherapy:clinical practice guidelines of the American Society of ClinicalOncology. J Clin Oncol, 2001, 19(5): 1539-1569.
  • 2Olivotto IA, Truong PT, Chua B. Postmastectomy radiation therapy:who needs it.. J Clin Oncol, 2004, 22(21) : 4237-4239.
  • 3Russell NS, Kunkler IH, van Tienhoven G, et al. Postmastectomyradiotherapy : will the selective use of postmastectomy radiothera-py study end the debate.. J Clin Oncol, 2009, 27(6) : 996-997.
  • 4Van Belle V, Van Calster B, Brouckaert O, et al. Qualitative assess-ment of the progesterone receptor and HER2 improves the Notting-ham Prognostic Index up to 5 years after breast cancer diagnosis. JClin Oncol, 2010, 28(27): 4129-4134.
  • 5Puente J, L6pez-Tamjella S, Ruiz A, et al. Practical prognosticindex for patients with metastatic recurrent breast cancer: retro-spective analysis of 2,322 patients from the GEICAM Spanish ElAlamo Register. Breast Cancer Res Treat, 2010, 122 (2 ) : 591 -600.
  • 6van Nes JG, Putter H, van Hezewijk M, et al. Tailored follow-up forearly breast cancer patients : a prognostic index that predictslocoregional recurrence. Eur J Surg Oncol, 2010,36(7) : 617-624.
  • 7Recht A, Gray R, Davidson NE, et al. Locoregional failure 10 yearsafter mastectomy and adjuvant chemotherapy with or without tamox-ifen without irradiation : experience of the Eastern CooperativeOncology Group. J Clin Oncol, 1999, 17(6) : 1689-1700.
  • 8王慧颖,董慧婷,刘群,邢鹏,李继光.腋淋巴结切除数目在判断腋淋巴结阴性乳腺癌患者预后中的作用[J].中华肿瘤杂志,2012,34(6):457-460. 被引量:8
  • 9Iyer RV, Hanlon A, Fowble B, et al. Accuracy of the extent of axil-lary nodal positivity related to primary tumor size, number of involvednodes, and number of nodes examined. Int J Radiat Oncol BiolPhys, 2000, 47(5): 1177 -1183.
  • 10Van der Hage JA, Putter H, Bonnema J,et al. Impact of locoregion-al treatment on the early-stage breast cancer patients : a retrospec-tive analysis. Eur J Cancer, 2003, 39( 15) : 2192-2199.

二级参考文献44

  • 1Tagbian A, Jeong JH, Mamounas E, et al. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy:results from five national surgical adjuvant breast and bowel project randomized clinical trials. J Clin Oncol, 2004, 22:4247-4254.
  • 2Katz A, Strom EA, Buchholz TA, et al. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy : implications for postoperative irradiation. J Clin Oncol, 2000, 18: 2817-2827.
  • 3Recht A,Gray R,Davidson NE,et al. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation:experience of the Eastern Cooperative Oncology Group. J Clin Oncol, 1999,17 : 1689-1700.
  • 4Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med, 1997,337:956-962.
  • 5Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med,1997 ,337 :949-955.
  • 6Overgaard M, Nielsen HM, Overgaard J. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes,as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b & c randomized trials. Radiother Oncol,2007 ,82 :247-253.
  • 7Smith BD, Smith GL, Haffty BG. Postmastectomy radiation and mortality in women with T1 -T2 node-positive breast cancer. J Clin Oncol,2005,23 : 1409-1419.
  • 8van der Hage JA,Putter H, Bonnema J, et al. Impact of locoregional treatment on the early-stage breast cancer patients : a retrospective analysis. Eur J Cancer,2003,39:2192-2199.
  • 9Buehholz TA, Woodward WA, Duan Z, et al. Radiation use and long-term survival in breast cancer patients with T1, T2 primary tumors and one to three positive axillary lymph nodes. Int J Radiat Oncol Biol Phys,2008,71 : 1022-1027.
  • 10Van de Steene J, Soete G, Storme G. Adjuvant radiotherapy for breast cancer significantly improves overall survival: the missing link. Radiother Oncol,2000,55:263-272.

共引文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部